Transgender women living with HIV may be hesitant to use antiretroviral therapy (ART) or not take it as prescribed because of concerns about drug interactions with feminising hormones, according to a presentation at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris.
"We don’t want to look back in 30 years and realise we missed the opportunity to make history by eliminating new HIV transmissions."
Even though there has been a major drop in new HIV cases in major Australian states, new research suggests there is a long way to go to end HIV.Australia has committed to ending new HIV transmissions by 2020, but the Critical Steps Towards Addressing HIV research found it has a lot of work to do to achieve that goal.
Daily pills may become a thing of the past for people who have HIV. A long-acting injection has been found to work just as well or better than standard pill-based antiretroviral therapy (ART) at preventing the virus from bouncing back and becoming infectious again.
At the end of a two-year trial of 286 people with HIV, 94 per cent of those who had injections of the long-acting therapy every eight weeks had the virus under control, defined as having less than 50 copies of the virus per millilitre of blood. A monthly form of the injection was effective in 87 per cent of those who had it, while standard ART pills worked for 84 per cent of those who took them.
New York City’s Bruce Richman is the award-winning founder of Prevention Access Campaign, the movement behind the U=U phenomenon. Bruce is coming to Australia as part of a nationwide U=U campaign from The Institute of Many (TIM) and Dynamix International and he'll be answering all your questions alongside medical/research professionals and other community members.
More Articles ...
- International AIDS Candlelight Memorial 2018
- Join us for a special event film screening: The Pink House
- What is Sex Positivity?
- 30 Ways to World AIDS Day